Back to Search Start Over

Changing haemodynamic status of patients referred for transcatheter aortic valve intervention during the COVID-19 pandemic.

Authors :
Ooms, Joris F.
Hokken, Thijmen W.
Adrichem, Rik
Gunes, Dilay
de Ronde-Tillmans, Marjo
Kardys, Isabella
Goudzwaard, Jeannette
Mattace-Raso, Francesco
Nuis, Rutger-Jan
Daemen, Joost
Van Mieghem, Nicolas M.
Source :
Netherlands Heart Journal; Oct2023, Vol. 31 Issue 10, p399-405, 7p
Publication Year :
2023

Abstract

Introduction: Delays in the diagnosis and referral of aortic stenosis (AS) during the coronavirus disease 2019 (COVID-19) pandemic may have affected the haemodynamic status of AS patients. We aimed to compare clinical and haemodynamic characteristics of severe AS patients referred for transcatheter aortic valve implantation (TAVI) or balloon aortic valvuloplasty (BAV) before the pandemic versus two subsequent periods. Methods: This study compared three 1‑year historical cohorts: a pre-COVID-19 group (PCOV), a 1st-year COVID-19 group (COV-Y1) and a 2nd-year COVID-19 group (COV-Y2). The main parameters were baseline New York Heart Association (NYHA) functional class, left ventricular ejection fraction (LVEF) and left ventricular end-diastolic pressure (LVEDP). Demographics, procedural characteristics and 30-day clinical outcomes were assessed. The transition time between heart team decision and TAVI was examined. Pairwise group comparisons were performed (PCOV vs COV-1Y and COV-1Y vs COV-2Y). Results: A total of 720 patients were included with 266, 249 and 205 patients in the PCOV, COV-Y1 and COV-Y2 groups, respectively. BAV was performed in 28 patients (4%). NYHA class did not differ across the cohorts. Compared to PCOV, LVEF was slightly lower in COV-Y1 (58% (49–60%) vs 57% (45–60%), p = 0.03); no difference was observed when comparing COV-Y1 and COV-Y2. LVEDP was higher in COV-Y1 than in PCOV (20 mm Hg (16–26 mm Hg) vs 17 mm Hg (13–24 mm Hg), p = 0.01). No difference was found when comparing LVEDP between COV-Y1 and COV-Y2. Thirty-day mortality did not differ between groups. Transition time was reduced in the COVID era. Duration of hospital stay declined over the study period. Conclusions: Patients undergoing TAVI during the COVID-19 pandemic had more advanced AS illustrated by lower LVEF and higher LVEDP, but there were no differences in clinical outcome. The TAVI pathway became more efficient. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15685888
Volume :
31
Issue :
10
Database :
Complementary Index
Journal :
Netherlands Heart Journal
Publication Type :
Academic Journal
Accession number :
172312974
Full Text :
https://doi.org/10.1007/s12471-023-01795-y